Thoughts on advancing the stem cell clinical research
10.3760/cma.j.issn.1006-1924.2020.01.017
- VernacularTitle:关于推进干细胞临床研究的思考
- Author:
Hongming TANG
1
;
Zhongmin LIU
Author Information
1. 同济大学附属东方医院干细胞转化医学产业基地上海干细胞临床转化研究院
- Keywords:
Stem cells;
Stem cell clinical research;
Biomedical industry
- From:
Chinese Journal of Medical Science Research Management
2020;33(1):79-80,封3-封4
- CountryChina
- Language:Chinese
-
Abstract:
Objective This study aims to analyze and investigate the major factors that affecting stem cell clinical research,explore corresponding countermeasures,to further promote the clinical research and translational application of stem cells.Methods Comprehensive investigation were conducted to analyze and summarize the the most recent basic research of stem cells,standardization of stem cell preparation sources,human personnel,clinical research and supporting systems.Results The slow progress of stem cell clinical research could attribute to several factors,including sluggish frontier basic research of stem cells;lack of high-quality,clear-source,and controllable samples for stem cell research institutes,lack of standard operation codes,professional consensus,guidelines in multi-center clinical research and stem cell research,and unsound supporting system of stem cell clinical research.Conclusions Based on the analysis and summaries,combined with the practice and exploration of the author in past decade.Our recommendations include:focus on human major diseases,strive to make breakthroughs in key scientific problems of stem cell and translational research,establish a national stem cell resource bank,and conduct multi-center stem cell clinical research.Besides,increase the effort in personnel training in various related fields,establish a scientific system and mechanism for the supervision of stem cell clinical research,accelerate the clinical research and translation of stem cells,and finally contribute to the "Healthy China 2030" national strategy to provide better service to public.
